Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Vanguard Morningstar Growth ETF
VUG
$231B
| $2M | ﹤0.01% |
41,382
-8,922
| -18% | -$444K |
|
477
Ross Stores
ROST
$81.9B
| $1.99M | ﹤0.01% |
18,248
-134
| -0.7% | -$16.1K |
|
478
MakeMyTrip
MMYT
$5.64B
| $1.98M | ﹤0.01% |
72,873
| – | – |
|
|
KYO
479
DELISTED
Kyocera Adr
KYO
| $1.96M | ﹤0.01% |
31,238
+502
| +2% | +$31.5K |
|
480
Baidu
BIDU
$37.2B
| $1.94M | ﹤0.01% |
12,606
-3,485
| -22% | -$572K |
|
481
VanEck Semiconductor ETF
SMH
$73.2B
| $1.93M | ﹤0.01% |
15,072
+30
| +0.2% | +$3.95K |
|
482
iShares Core MSCI EAFE ETF
IEFA
$196B
| $1.91M | ﹤0.01% |
25,704
-447
| -2% | -$34K |
|
483
lululemon athletica
LULU
$14.6B
| $1.9M | ﹤0.01% |
+4,689
| New | +$1.88M |
|
484
Myriad Genetics
MYGN
$312M
| $1.9M | ﹤0.01% |
58,767
+5,013
| +9% | +$166K |
|
485
Fidelity National Information Services
FIS
$22.1B
| $1.9M | ﹤0.01% |
15,589
-656
| -4% | -$88K |
|
486
GE Aerospace
GE
$384B
| $1.88M | ﹤0.01% |
29,331
-2,877
| -9% | -$185K |
|
|
REP
487
DELISTED
REPSOL YPF SA ADS(RP 1 CAP SH)
REP
| $1.87M | ﹤0.01% |
142,840
+6,351
| +5% | +$83.1K |
|
488
Trane Technologies
TT
$106B
| $1.84M | ﹤0.01% |
10,680
+73
| +0.7% | +$14K |
|
489
Altria Group
MO
$114B
| $1.83M | ﹤0.01% |
40,293
+2,125
| +6% | +$103K |
|
490
Amdocs
DOX
$6.22B
| $1.83M | ﹤0.01% |
24,216
+29
| +0.1% | +$2.24K |
|
491
Tyson Foods
TSN
$20.4B
| $1.81M | ﹤0.01% |
22,943
-647
| -3% | -$48.8K |
|
492
EPAM Systems
EPAM
$5.03B
| $1.78M | ﹤0.01% |
3,122
-529
| -14% | -$311K |
|
493
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.9B
| $1.74M | ﹤0.01% |
30,970
-1,290
| -4% | -$74.4K |
|
494
Hormel Foods
HRL
$13.8B
| $1.71M | ﹤0.01% |
41,692
-275
| -0.7% | -$12.4K |
|
495
Progressive
PGR
$125B
| $1.69M | ﹤0.01% |
18,705
-487
| -3% | -$46.4K |
|
496
Broadcom
AVGO
$2.04T
| $1.64M | ﹤0.01% |
33,860
+3,820
| +13% | +$186K |
|
497
Petrobras Class A
PBR.A
$103B
| $1.64M | ﹤0.01% |
164,202
| – | – |
|
498
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $1.56M | ﹤0.01% |
17,836
-9,934
| -36% | -$871K |
|
|
LHCG
499
DELISTED
LHC Group LLC
LHCG
| $1.55M | ﹤0.01% |
9,872
+2,876
| +41% | +$540K |
|
500
Anika Therapeutics
ANIK
$287M
| $1.53M | ﹤0.01% |
36,012
+3,151
| +10% | +$130K |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.